Nuclear Medicine Pipeline

We are developing a pipeline of targeted radiopharmaceuticals to serve major unmet therapeutic and diagnostic needs of patients with cancer.

All development candidates are exclusively derived from internal discovery efforts and aimed at theranostic combinations based on the same targeting molecule.

 

> click to enlarge

Innovative radiopharmaceuticals Cancer drug development. Innovative radiopharmaceuticals Cancer drug development at 3BP.